1. De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. Issue 5 (May 2022) Authors: Nitz, Ulrike; Gluz, Oleg; Graeser, Monika; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Braun, Michael; Augustin, Doris; Potenberg, Jochem; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; zu Eulenburg, Chris... Journal: Lancet oncology Issue: Volume 23:Issue 5(2022) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differential impact of prognostic parameters in hormone receptor–positive lobular breast cancer. Issue 22 (11th August 2020) Authors: Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Fred... Journal: Cancer Issue: Volume 126:Issue 22(2020) Page Start: 4847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2018) Authors: Colleoni, Marco; Luo, Weixiu; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Hitre, Erika; Graas, Marie-Pascale; Simoncini, Edda; Kamby, Claus; Thompson, Alastair; Loibl, Sibylle; Gavilá, Joaquín; Kuroi, Katsumasa; Marth, Christian; Müller, Bettina; O'Reilly, Seam... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer. (January 2023) Authors: Reimer, Toralf; Stachs, Angrit; Veselinovic, Kristina; Polata, Silke; Müller, Thomas; Kühn, Thorsten; Heil, Jörg; Ataseven, Beyhan; Reitsamer, Roland; Hildebrandt, Guido; Knauer, Michael; Golatta, Michael; Stefek, Andrea; Zahm, Dirk-Michael; Thill, Marc; Nekljudova, Valentina; Krug, David; Loibl,... Journal: EClinicalMedicine Issue: Volume 55(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗